![](/img/cover-not-exists.png)
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
Srikala S. Sridhar, Eric Winquist, Andrea Eisen, Sebastien J. Hotte, Elaine McWhirter, Ian F. Tannock, Som D. Mukherjee, Lisa Wang, Chantale Blattler, John J. Wright, Malcolm J. MooreVolume:
29
Language:
english
Pages:
5
DOI:
10.1007/s10637-010-9408-4
Date:
October, 2011
File:
PDF, 107 KB
english, 2011